WCA
ZYME icon

Windsor Creek Advisors’s Zymeworks ZYME Stock Holding History

Windsor Creek Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-17,002
Closed -$792K – 214
2020
Q3 		$792K Buy
17,002
+1,054
+7% +$36.2K 0.23% 86
2020
Q2 		$575K Buy
+15,948
New +$587K 0.19% 96

Other funds holding ZYME

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Windsor Creek Advisors's ZYME Position: Q4 2020 in Review

Windsor Creek Advisors sold out of Zymeworks (ZYME) in Q4 2020, closing a stake of 17,002 shares — an estimated $792K sold.

Windsor Creek Advisors first reported a position in ZYME in Q2 2020 and held it in 2 quarters. The position peaked at $792K in Q3 2020. 138 funds tracked by Wall St. Rank hold ZYME as of Q4 2020.

  • Windsor Creek Advisors reported no remaining Zymeworks position as of Q4 2020 after selling out during the quarter.
  • Windsor Creek Advisors sold 17,002 Zymeworks shares in Q4 2020, an estimated $792K.
  • Windsor Creek Advisors first reported a position in Zymeworks in Q2 2020 and held it in 2 quarters.
  • Windsor Creek Advisors's Zymeworks position peaked at $792K in Q3 2020.
  • 138 funds tracked by Wall St. Rank held Zymeworks as of Q4 2020.

Based on Windsor Creek Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.